ArticleMedicina (Kaunas, Lithuania)2024

Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM).

Josip Batinić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.